米非司酮与乳酸依沙吖啶联合用于瘢痕子宫中期妊娠终止的价值探讨

The value discussion of treating scarred uterus mid pregnancy termination with mifepristone combining ethacridine lactate

目的:探讨米非司酮与乳酸依沙吖啶联合用于瘢痕子宫中期妊娠终止的临床疗效。方法:收集2013年6月-2015年6月我院收治的瘢痕子宫中期妊娠终止产妇54例为研究对象,将54例研究对象随机分为观察组与对照组,观察组给予米非司酮联合乳酸依沙吖啶引产,对照组仅给予乳酸依沙吖啶引产,对比分析两组患者引产成功率、出血量、不良反应发生情况及其他观察指标。结果:观察组引产成功率高于对照组,不良反应发生率低于对照组,产后2h出血量、用药到宫缩时间、用药至胎儿排出时间等方面均优于对照组,数据差异显著(P<0.05)。结论:米非司酮联合乳酸依沙吖啶在瘢痕子宫中期妊娠终止中的临床疗效显著,建议在临床上推广。

Objective:To discuss the clinical effect of treating scarred uterus mid pregnancy termination with mifepristone combining ethacridine lactate.Methods:Choosed 54 cases of scarred uterus mid pregnancy termination from Jun.2013 to Jun.2015 to divide into study group and controlled group.The study group were treated with mifepristone combining ethacridine lactate,the controlled group were treated with ethacridine lactate only.Compared the success rate of induced labor,amount of blood,adverse effects.Results:The success rate of induced labor of study group was higher than controlled group,the adverse effects was lower than controlled group(P<0.05).Conclusion:treating scarred uterus mid pregnancy termination with mifepristone combining ethacridine lactate is effective to extend in clinic.